Exportar Publicação

A publicação pode ser exportada nos seguintes formatos: referência da APA (American Psychological Association), referência do IEEE (Institute of Electrical and Electronics Engineers), BibTeX e RIS.

Exportar Referência (APA) 
Bravo, A. M. & Crespo de Carvalho, J. (2013). Understanding pharmaceutical sustainable supply chains – a case study application. Independent Journal of Management and Production. 4 (1), 228-247
Exportar Referência (IEEE) 
A. M. Bravo and J. L. Carvalho,  "Understanding pharmaceutical sustainable supply chains – a case study application", in Independent Journal of Management and Production, vol. 4, no. 1, pp. 228-247, 2013
Exportar BibTeX 
@article{bravo2013_1731867644407,
	author = "Bravo, A. M. and Crespo de Carvalho, J.",
	title = "Understanding pharmaceutical sustainable supply chains – a case study application",
	journal = "Independent Journal of Management and Production",
	year = "2013",
	volume = "4",
	number = "1",
	doi = "10.14807/ijmp.v4i1.72",
	pages = "228-247",
	url = "http://www.ijmp.jor.br/index.php/ijmp/index"
}
Exportar RIS 
TY  - JOUR
TI  - Understanding pharmaceutical sustainable supply chains – a case study application
T2  - Independent Journal of Management and Production
VL  - 4
IS  - 1
AU  - Bravo, A. M.
AU  - Crespo de Carvalho, J.
PY  - 2013
SP  - 228-247
SN  - 2236-269X
DO  - 10.14807/ijmp.v4i1.72
UR  - http://www.ijmp.jor.br/index.php/ijmp/index
AB  - A major paradigm change is occurring in the pharmaceutical industry and an increase of returnsand recalls has been seen; although this industry in known for the continuoussearch for quality and regulatory compliance.Hence, in this paperwe combine the findings of previous literature reviews conducted by theauthors. Essentially, explore the links between pharmaceutical drugs quality,reverse logistics, and sustainability. A case study on a global corporation manufacturing in the area of generic drug products has been selected andcorrelations are done with regards to returns and recalls from hospitalpharmacies, in particular. With this approach it is expected to link bothparties in the application of a quality by design risk management approach aswell as reduce variability and risk of noncompliance.
ER  -